Clinical Trial Update: Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of Proxinium for squamous cell carcinoma of the head and neck was terminated. This update confirms the trial status as TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Proxinium

Snippet

Sponsor: Sesen Bio, Inc. | Conditions: Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell | Phase 2 | Status: TERMINATED